Javid Moslehi, MD
Vanderbilt University Medical Centre
Nashville, TN, USA
Javid Moslehi is an associate professor of medicine at Vanderbilt School of Medicine. Dr Moslehi directs the cardio-oncology programme, a clinical and research programme focused on cardiovascular health of cancer patients.
Dr Moslehi also directs a research laboratory, with general interests that include: mechanisms of cardiovascular toxicities that occur as a result of targeted cancer therapies, adverse effects of tumours on the cardiovascular and metabolic systems, cancers that arise from the heart, and the growing appreciation that common risk factors (including genetic mutations) predispose to both cancer and cardiovascular disease. The Moslehi laboratory uses an integrated approach from molecules, cell-based and animal models, and systems biology towards these goals. The laboratory is well integrated into the Vanderbilt cardio-oncology clinical programme, with the hope that discoveries in the laboratory will translate into clinical practice.
Dr Moslehi graduated from Johns Hopkins University and University of Connecticut School of Medicine. After completing an internal medicine residency at Johns Hopkins Hospital and clinical cardiology fellowship at the Brigham and Women's Hospital and Harvard Medical School, he undertook a basic science postdoctoral fellowship at the Dana-Farber Cancer Institute, focusing on the role of angiogenesis in heart disease. In 2009, he founded the cardio-oncology programme at Brigham and Women's Hospital/Dana-Farber Cancer Institute and Harvard Medical.